Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DIEM DIANA DANG

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1255819991
CMS profile
11086029
Location
FORT WORTH, TX

General Payments · PY2021–2024

$2,093.84

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$744.97

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $744.97 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $194.11 10
Novo Nordisk AS $164.03 5
PFIZER INC. $142.25 10
ALK-Abello, Inc $47.52 2
Lilly USA, LLC $45.01 2
Amgen Inc. $32.32 2
Inspire Medical Systems, Inc. $29.70 2
GlaxoSmithKline, LLC. $20.95 1
Sumitomo Pharma America, Inc. $18.85 1
Xeris Pharmaceuticals, Inc. $18.65 1
Organon LLC $16.14 1
Acerta Pharma LLC $15.44 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $565.16 44
PY2022 $323.38 20
PY2023 $460.33 15
PY2024 $744.97 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.81 03/25/2024 Food and Beverage Undisputed 01/23/2026 1106982651 CMS
ABBVIE INC. $33.27 04/20/2024 Food and Beverage Undisputed 01/23/2026 1106982653 CMS
ABBVIE INC. $26.95 05/10/2024 Food and Beverage Undisputed 01/23/2026 1106982655 CMS
ABBVIE INC. $9.60 06/20/2024 Food and Beverage Undisputed 01/23/2026 1106982657 CMS
ABBVIE INC. $27.40 06/26/2024 Food and Beverage Undisputed 01/23/2026 1106982659 CMS
ABBVIE INC. $25.68 08/08/2024 Food and Beverage Undisputed 01/23/2026 1106982661 CMS
ABBVIE INC. $26.45 08/26/2024 Food and Beverage Undisputed 01/23/2026 1106982663 CMS
ABBVIE INC. $6.81 09/23/2024 Food and Beverage Undisputed 01/23/2026 1106982665 CMS
ABBVIE INC. $6.92 10/30/2024 Food and Beverage Undisputed 01/23/2026 1106982667 CMS
ABBVIE INC. $22.22 11/12/2024 Food and Beverage Undisputed 01/23/2026 1106982669 CMS
ALK-Abello, Inc $24.63 07/16/2024 Food and Beverage Undisputed 01/23/2026 1099890017 CMS
ALK-Abello, Inc $22.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 1099890015 CMS
Amgen Inc. $16.75 07/15/2024 Food and Beverage Undisputed 01/23/2026 1115549964 CMS
Amgen Inc. $15.57 09/23/2024 Food and Beverage Undisputed 01/23/2026 1115549971 CMS
AstraZeneca Pharmaceuticals LP $15.44 07/18/2024 Food and Beverage Undisputed 01/23/2026 1104619424 CMS
GlaxoSmithKline, LLC. $20.95 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116474479 CMS
Inspire Medical Systems, Inc. $14.85 06/05/2024 Food and Beverage Undisputed 01/23/2026 1148144359 CMS
Inspire Medical Systems, Inc. $14.85 06/05/2024 Food and Beverage Undisputed 01/23/2026 1148144364 CMS
Lilly USA, LLC $29.49 03/08/2024 Food and Beverage Undisputed 01/23/2026 1135634776 CMS
Lilly USA, LLC $15.52 05/01/2024 Food and Beverage Undisputed 01/23/2026 1135623991 CMS
Novo Nordisk Inc $89.29 04/11/2024 Food and Beverage Undisputed 01/23/2026 1100587811 CMS
Novo Nordisk Inc $11.30 04/16/2024 Food and Beverage Undisputed 01/23/2026 1100632325 CMS
Novo Nordisk Inc $17.00 06/27/2024 Food and Beverage Undisputed 01/23/2026 1100533959 CMS
Novo Nordisk Inc $21.85 07/29/2024 Food and Beverage Undisputed 01/23/2026 1100387051 CMS
Novo Nordisk Inc $24.59 09/30/2024 Food and Beverage Undisputed 01/23/2026 1100618786 CMS
Organon Llc $16.14 11/18/2024 Food and Beverage Undisputed 01/23/2026 1136229738 CMS
PFIZER INC. $17.26 01/24/2024 Food and Beverage Undisputed 01/23/2026 1131020988 CMS
PFIZER INC. $16.98 03/14/2024 Food and Beverage Undisputed 01/23/2026 1131271647 CMS
PFIZER INC. $18.38 04/02/2024 Food and Beverage Undisputed 01/23/2026 1131283153 CMS
PFIZER INC. $20.26 05/08/2024 Food and Beverage Undisputed 01/23/2026 1131512276 CMS
PFIZER INC. $20.74 06/19/2024 Food and Beverage Undisputed 01/23/2026 1131670631 CMS
PFIZER INC. $3.31 07/02/2024 Food and Beverage Undisputed 01/23/2026 1132054578 CMS
PFIZER INC. $19.35 09/04/2024 Food and Beverage Undisputed 01/23/2026 1131854709 CMS
PFIZER INC. $3.83 10/04/2024 Food and Beverage Undisputed 01/23/2026 1132068619 CMS
PFIZER INC. $19.50 11/04/2024 Food and Beverage Undisputed 01/23/2026 1132075717 CMS
PFIZER INC. $2.64 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131161084 CMS
Sumitomo Pharma America, Inc. $18.85 08/05/2024 Food and Beverage Undisputed 01/23/2026 1148954292 CMS
Xeris Pharmaceuticals, Inc. $18.65 10/11/2024 Food and Beverage Undisputed 01/23/2026 1144624837 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.